cline, ampicillin, carbenicillin, ticarcillin, cephalothin, cefazolin, cefoxitin, cefotetan, ceftazidime, gentamicin, tobramycin, amikacin, trimethoprim/sulfamethoxazole, and ciprofloxacin. Gram-negative susceptibility cards were used according to the manufacturer's instructions. To determine the susceptibility of the strains to chloramphenicol, the agar diffusion disk method as outlined by the National Committee for Clinical Laboratory Standards (NCCLS) 21 was used. Monthly quality control evaluations of the susceptibility cards and the antimicrobial susceptibility disks c were performed with Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 27853). The MIC breakpoint determinations, interpretative categories, and quality control procedures were those recommended by the manufacturer and NCCLS. [21] [22] [23] On repeat MIC testing, we found that the MIC of each antimicrobial agent was the same as the initial MIC or was within a 2-fold dilution.
The 5 S. anatum isolates cultured by the UWVMTH prior to April 1991 possessed limited antimicrobial resistance. Only 1 of the 5 isolates examined was drug resistant. This isolate was resistant to tetracycline and chloramphenicol (data not shown). The 15 S. anatum isolates obtained between April 1991 and August 1992 were resistant to multiple antimicrobial agents and could be separated into 4 groups based on their patterns of resistance ( Table 1 ). The isolates in each group were resistant to the same antimicrobial agents as were those in the previous group and were also resistant to 1 or more additional antimicrobial agents. Group I possessed resistance to ampicillin, tetracycline, chloramphenicol, carbenicillin (≥ 512 µg/ml), and ticarcillin (≥ 256 µg/ml). In addition to these drugs, group II was also resistant to gentamicin (≥ 16 µg/ml) and tobramycin (≥ 16 µg/ml). Group III was also resistant to trimethoprim/sulfamethoxazole (≥ 320 µg/ ml). Group IV, the most resistant group, was resistant to the same antimicrobial agents as were the group III organisms and to cephalothin (≥ 32 µg/ml). None of the tested organisms were resistant to amikacin, ciprofloxacin, cefazolin, cefoxitin, cefotetan, or ceftazidime.
The emergence of antimicrobial-resistant strains of Salmonella has become an accelerating problem in recent years. 5 The multidrug resistance possessed by the S. anatum in this study had not been observed at the UWVMTH prior to April 1991. In addition, similar multidrug resistance was not observed in previous susceptibility studies. In these studies, infrequent resistance to tetracycline, chloramphenicol, and ampicillin was reported. 3, 4, 6, 16, 19 For example, in 1 report of 19 S. anatum isolates, 4 26% were resistant to tetracycline, 21% were resistant to chloramphenicol, and none were resistant to ampicillin. In another study, of 72 isolates of S. anatum, 16 40% were resistant to ampicillin, 16% were resistant to chloramphenicol, and 13% were resistant to tetracycline. In our study, all 15 isolates were resistant to tetracycline, chloramphenicol, and ampicillin. In addition, 60% and 85% of the MDR isolates in our study were resistant to trimethoprim/sulfamethoxazole and gentamicin, respectively. Resistance to these 2 antimicrobial agents was not reported by previous investigators. 3, 4, 6, 16, 19 However, similar multidrug resistance has been reported for S. krefeld, S. saintpaul, and S. agona isolated from horses. 7, 15, 18 The isolates described in these reports were resistant to multiple antimicrobial agents, including ampicillin, cephalothin, carbenicillin, gentamicin, tobramycin, tetracycline, chloramphenicol, and trimethoprim/sulfa compounds. Thus, it appears that the S. anatum isolates described in this report possess multidrug resistance that has not been previously reported for S. anatum and has only been observed in other Salmonella serotypes, MDR S. anatum represent an important public health hazard for several reasons. Infected horses, including asymptomatic carriers, often shed Salmonella for several weeks or months. 20, 25 Additionally, S. anatum has been isolated from human beings. 1, 4 Therefore, individuals or animals that have contact with horses infected with MDR S. anatum or with materials contaminated by such organisms are at risk of becoming infected. For example, there have been several outbreaks of nosocomial equine salmonellosis in veterinary hospitals, which resulted in considerable financial losses and the temporary closure of 1 teaching hospital. 3, 13 Veterinarians have also acquired salmonellosis after handling infected animals. 2, 17 These examples of nosocomial outbreaks and zoonotic transmission underscore the potential public health hazard that MDR S. anatum represent. In addition, these isolates are a significant hazard because of the antimicrobial resistance they possess to ampicillin, chloramphenicol, and trimethoprim/sulfamethoxazole, drugs frequently used for the treatment of human salmonellosis. 14 biochemical tests, improved accuracy, and decreased time and cost. However, few of these systems include organisms of veterinary origin in their databases. Evaluations of a commercial system for enteric organisms found biotype differences between human and veterinary strains of gram-negative bacteria. 4,10 These biotype differences may affect the ability of a system to accurately identify organisms from veterinary sources. Recently, a commercial system for the 4-hour identification of medically important nonfermentative, gramnegative bacilli has been developed, Although this system has been evaluated using a large number of isolates of human origin, it has not been evaluated using isolates from animals. 7 The purpose of this study was to evaluate the ability of this system to identify gram-negative, nonfermentative and weakly fermentative bacilli from animals.
A total of 273 bacterial isolates from various animal species were tested. Isolates from swine respiratory disease (SRD) (Actinobacillus pleuropneumoniae, Bordetella bronchoseptica and Pasteurella multocida) and from bovine respiratory dis-
